
The Right Incentives for Global Vaccine Access
May 19, 2021 Michele Goodwin & Gregory Shaffer show how US support for a COVID-19 intellectual-property waiver could change pharmaceutical firms’ calculations.
Michele Goodwin is a professor at the University of California, Irvine and Director of the Center for Biotechnology and Global Health Policy.
May 19, 2021 Michele Goodwin & Gregory Shaffer show how US support for a COVID-19 intellectual-property waiver could change pharmaceutical firms’ calculations.